Table 2.
Clinical Characteristics of 88 Patients with Metachronous Krukenberg Tumors
| Variable | Metastasectomy n=71 (%) | Nonmetastasectomy n=17 (%) | p value |
|---|---|---|---|
| Age | 0.618 | ||
| ≥45 | 34 (47.9) | 7 (41.2) | |
| <45 | 37 (52.1) | 10 (58.8) | |
| Year of diagnosis | 0.552 | ||
| 2006–2008 | 21 (29.6) | 3 (17.6) | |
| 2009–2012 | 26 (36.6) | 6 (35.3) | |
| 2013–2016 | 24 (33.8) | 8 (47.1) | |
| Menstrual status | 0.507 | ||
| Premenopausal | 44 (62.0) | 12 (70.6) | |
| Postmenopausal | 27 (38.0) | 5 (29.4) | |
| Tumor location | 0.394 | ||
| Upper 1/3 | 12 (16.9) | 1 (5.9) | |
| Middle 1/3 | 12 (16.9) | 1 (5.9) | |
| Lower 1/3 | 42 (59.2) | 14 (82.3) | |
| Whole stomach | 5 (7.0) | 1 (5.9) | |
| Linitis plastica | 0.616 | ||
| Yes | 5 (7.0) | 2 (11.8) | |
| No | 66 (93.0) | 15 (88.2) | |
| Signet-ring cells | 0.493 | ||
| Yes | 23 (32.4) | 7 (41.2) | |
| No | 48 (67.6) | 10 (58.8) | |
| Laterality | 1.000 | ||
| Bilateral | 53 (74.6) | 13 (76.5) | |
| Unilateral | 18 (25.4) | 4 (23.5) | |
| Tumor size | 8.9±4.8 | 7.3±4.2 | 0.322 |
| Pathologic differentiation | 0.066 | ||
| Differentiated | 5 (7.0) | 4 (23.5) | |
| Undifferentiated | 66 (93.0) | 13 (76.5) | |
| Other types of metastasis | 33 (46.5) | 11 (64.7) | 0.233 |
| Peritoneum | 33 (46.5) | 6 (35.3) | 0.404 |
| Liver | 1 | 1 | |
| Supraclavicular lymph node | 0 | 1 | |
| Bone | 2 | 0 | |
| Lung | 1 | 0 | |
| Other | 1 | 4 | |
| Ascites | 0.951 | ||
| Yes | 34 (47.9) | 8 (47.1) | |
| No | 37 (52.1) | 9 (52.9) | |
| Procedure of gastrectomy | 0.357 | ||
| Distal gastrectomy | 49 (69.0) | 9 (53.0) | |
| Proximal gastrectomy | 5 (7.0) | 1 (5.9) | |
| Total gastrectomy | 17 (24.0) | 7 (41.1) | |
| Systemic chemotherapy | 0.231 | ||
| Yes | 48 (67.6) | 14 (82.4) | |
| No | 23 (32.4) | 3 (17.6) |